Methylprednisolone Unknown Status Phase 2 Trials for Early and Severe Systemic Sclerosis Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00379431A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab